Purdue Wants Fed. Circ. To Rehear OxyContin Patent Claims
Prescription opioid maker Purdue Pharma asked the full Federal Circuit to reconsider an opinion upholding a Patent Trial and Appeal Board decision invalidating claims in a patent covering abuse-deterrent formulations of...To view the full article, register now.
Already a subscriber? Click here to view full article